Dung “Zung” Thai, M.D., Ph. D.

Zung has been Senior Clinical Advisor at BioTheryX since December 2020. He is Chief Medical Officer at REMD Biotherapeutics where he leads clinical efforts in metabolism and oncology. He has held leadership roles at small and large companies including Amgen, Gilead Sciences, Atara, Arresto, and Anza Biotherapeutics where he led the development of small molecule and protein therapeutics in metabolism, oncology, and fibrotic diseases. Zung earned an A.B. from Cornell University and his M.D. and Ph.D. in pharmacology from the University of Pittsburgh School of Medicine. He was a fellow and clinical instructor in the department of clinical pharmacology at University of California, San Francisco. Zung was a post-doctoral fellow at the University of California, Berkeley and Carnegie Mellon University.